Cargando…

PReS-FINAL-1017: Antioxidant superoxide dismutase activity is elevated in jia but not associated with disease activity

Detalles Bibliográficos
Autores principales:	Radziszewska, A, Rowden, C, Suffield, L, Ursu, S, Kassoumeri, L, Wedderburn, LR, Ioannou, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044480/ http://dx.doi.org/10.1186/1546-0096-11-S2-P14

Ejemplares similares

PReS-FINAL-1009: Antioxidant superoxide dismutase activity is paradoxically normal in juvenile systemic lupus erythematosus
por: Radziszewska, A, et al.
Publicado: (2013)

Can inflammatory markers predict response to methotrexate in JIA? Results from the CHARM study
por: Moncrieffe, H, et al.
Publicado: (2011)

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
por: Ursu, S, et al.
Publicado: (2011)

PReS13-SPK-1478: New developments in our care & understanding of JIA
por: Wedderburn, L
Publicado: (2013)

PReS-FINAL-2254: Is it systemic JIA or post infectious illness?
por: Guddeti, P, et al.
Publicado: (2013)

PReS-FINAL-1007: Regulatory T cells functional specialization in JIA
por: Mijnheer, G, et al.
Publicado: (2013)

Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study
por: Mulligan, K, et al.
Publicado: (2008)

PReS-FINAL-1001: Lymphocytes from the inflamed joint of juvenile idiopathic arthritis patients express reduced levels of cd73 and have a functional defect in adenosine production
por: Botta Gordon-Smith, S, et al.
Publicado: (2013)

PReS-FINAL-2057: Systemic onset JIA with coronary artery dilatation
por: Aktay Ayaz, N, et al.
Publicado: (2013)

PReS-FINAL-1018: Can the CD4/CD8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
por: De Leeuw, S, et al.
Publicado: (2013)

PReS-FINAL-1004: Can the cd4/cd8β ratio be used as a predictive biomarker in extended-to-be oligoarticular JIA?
por: de Leeuw, S, et al.
Publicado: (2013)

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
por: Hirani, SP, et al.
Publicado: (2008)

PReS-FINAL-2058: Lipid peroxides, lipophuscin, sulfhydryl groups and TOS in children with JIA
por: Mazur Zielinska, H, et al.
Publicado: (2013)

PReS-FINAL-2050: Determination of the concentration of methotrexate in the blood serum of patients with JIA
por: Rokhlina, F, et al.
Publicado: (2013)

PReS-FINAL-2035: Fatty acid profiling: potential new biomarkers in JIA
por: Boros, C, et al.
Publicado: (2013)

PReS-FINAL-2055: Is there a necessity for patients with JIA to wear orthopedic insoles?
por: Kreuzpointner, F, et al.
Publicado: (2013)

PReS-FINAL-2065: Oxidative stress is associated to disease activity in a large cohort of JIA at transitional period
por: Wipff, J, et al.
Publicado: (2013)

PReS-FINAL-2047: Exploring the effectiveness of stretch and cast treatment of fixed flexion deformity in children with active JIA
por: Haggart, E, et al.
Publicado: (2013)

PReS-FINAL-2038: Clinical efficacy and tolerability of tocilizumab in patients with persistant systemic JIA
por: Mihailova, D, et al.
Publicado: (2013)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

PReS-FINAL-2170: Work disability in adult patients with juvenile idiopathic arthritis (JIA)
por: Goldenstein-Schainberg, C, et al.
Publicado: (2013)

PReS-FINAL-2246: CBCT versus orthopan tomogram detecting TMJ alteration in JIA
por: Arvonen, P, et al.
Publicado: (2013)

PReS-FINAL-1021: Further characterization of CD161+ regulatory t cells in health and disease
por: Duurland, CL, et al.
Publicado: (2013)

PReS-FINAL-2073: The usefulness of musculoskeletal ultrasound in monitoring efficacy of intraarticular infliximab therapy in JIA patients
por: Vidovic, M, et al.
Publicado: (2013)

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
por: Lu, P, et al.
Publicado: (2013)

Superoxide Dismutases and Superoxide Reductases
por: Sheng, Yuewei, et al.
Publicado: (2014)

PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept
por: Nicolai, R, et al.
Publicado: (2013)

PReS-FINAL-2051: The difference of disease's perception by JIA patients and their parents: analysis of the JAMAR questionnaire
por: Vanoni, F, et al.
Publicado: (2013)

Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy
por: Radziszewska, Anna, et al.
Publicado: (2014)

PReS-FINAL-1011: Can repeated T cell receptor stimulation lead to epigenetic reprogramming of the treg-specific demethylated region in human conventional T cells?
por: Wu, Q, et al.
Publicado: (2013)

PReS-FINAL-2045: Mutational analysis of sialic acid acetylesterase (siae) in juvenile idiopathic arthritis (JIA)
por: Tsitsami, E, et al.
Publicado: (2013)

PReS-FINAL-2062: The need for conducting different rehabilitation complexes for patients with juvenile idiopathic arthritis (JIA)
por: Shelepina, TA, et al.
Publicado: (2013)

Anakinra Activates Superoxide Dismutase 2 to Mitigate Inflammasome Activity
por: Pariano, Marilena, et al.
Publicado: (2021)

Copper primes adaptation of uropathogenic Escherichia coli to superoxide stress by activating superoxide dismutases
por: Saenkham, Panatda, et al.
Publicado: (2020)

PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland
por: Moraitis, E, et al.
Publicado: (2013)

PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)
por: Perfetti, F, et al.
Publicado: (2013)

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013)

Astaxanthin Prevents Decreases in Superoxide Dismutase 2 Level and Superoxide Dismutase Activity in Helicobacter pylori-infected Gastric Epithelial Cells
por: Kim, Suhn Hyung, et al.
Publicado: (2019)

Neonatal Extracellular Superoxide Dismutase Knockout Mice Increase Total Superoxide Dismutase Activity and VEGF Expression after Chronic Hyperoxia
por: Mathias, Maxwell, et al.
Publicado: (2021)

PReS13-SPK-1576: Unmeet needs in JIA treatment
por: Ruperto, N
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p8lfvc9nukr55o6kd5itl29hu2